Akeso Inc Ordinary Shares 09926
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- HK$108.70
- Day Range
- HK$103.70–107.80
- 52-Week Range
- HK$80.20–156.00
- Bid/Ask
- HK$106.70 / HK$106.80
- Shares Outstanding
- 921.14M
- Market Cap
- HK$98.38B
- Volume/Avg
- 5M / 12M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 25.36
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company has developed more than 50 drug candidates, including 15 bispecific antibody/multispecific antibody/bispecific antibody ADC/ADC/TCE drugs, with 27 drugs in clinical development. The majority of the company's revenue is derived from Mainland China, and it also has its presence in the USA and Other regions.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Growth
- Total Number of Employees
- 4,082
- Website
- https://www.akesobio.com
Valuation
|
Metric
|
09926
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 10.31 |
Price/Sales | 25.36 |
Price/Cash Flow | — |
Price/Earnings
09926
Financial Strength
|
Metric
|
09926
|
|---|---|
Quick Ratio | 3.59 |
Current Ratio | 4.01 |
Interest Coverage | −8.93 |
Quick Ratio
09926
Profitability
|
Metric
|
09926
|
|---|---|
Return on Assets (Normalized) | −3.57% |
Return on Equity (Normalized) | −6.93% |
Return on Invested Capital (Normalized) | −5.68% |
Return on Assets
09926
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|^QQD#!K | LOCK|w%p%x | $128B | |||
| Moderna Inc
MRNA
| LOCK|zK>#Jx | LOCK|c^ | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|&>?B?& | LOCK|t>zw | $76B | |||
| argenx SE ADR
ARGX
| LOCK|^^yTSl? | LOCK|X@ | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>B^>mJ | LOCK|$Xj | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|$vpjV!W | LOCK|Yrt%< | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|SGmnS@h | LOCK|XtwL | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|^%<>xFY | LOCK|?j^ | $24B | |||
| Incyte Corp
INCY
| LOCK|YyH@<s | LOCK|ll | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|qqyW^&p | LOCK|%Vj | $15B |
United States